What is Nuvation Bio's derivatives, gross, liabilities?

Nuvation Bio (NUVB) reported derivatives, gross, liabilities of $2.87M in Q4 2025.

How has Nuvation Bio's derivatives, gross, liabilities changed year-over-year?

Nuvation Bio's derivatives, gross, liabilities increased by 39.6% year-over-year, from $2.05M to $2.87M.

What is the long-term trend for Nuvation Bio's derivatives, gross, liabilities?

Over 4 years (2021 to 2025), Nuvation Bio's derivatives, gross, liabilities has grown at a -28.6% compound annual growth rate (CAGR), from $11.04M to $2.87M.

Nuvation Bio NUVB Derivatives, gross, liabilities

Derivatives, gross, liabilities at other companies

Apollo Global ManagementAPO

$5.84B+73.4%

State StreetSTT

$25.58B+36.6%

BKBK

$9.12B+68.1%

Wells Fargo & CompanyWFC

$92.29B+26.4%

3MMMM

$297M—

American International GroupAIG

$412M-24.5%

Other financials

Income statement

See full

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

See full

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

See full

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

See full

Market cap$2.25B+150%

Profitability

See full

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

See full

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:DerivativeFairValueOfDerivativeLiability.

The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's derivatives, gross, liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nuvation Bio's derivatives, gross, liabilities?: Nuvation Bio (NUVB) reported derivatives, gross, liabilities of $2.87M in Q4 2025.
How has Nuvation Bio's derivatives, gross, liabilities changed year-over-year?: Nuvation Bio's derivatives, gross, liabilities increased by 39.6% year-over-year, from $2.05M to $2.87M.
What is the long-term trend for Nuvation Bio's derivatives, gross, liabilities?: Over 4 years (2021 to 2025), Nuvation Bio's derivatives, gross, liabilities has grown at a -28.6% compound annual growth rate (CAGR), from $11.04M to $2.87M.